The promise of direct-to-consumer COVID-19 testing: ethical and regulatory issues

Widespread diagnostic and serological (antibody) testing is one key to mitigating the COVID-19 pandemic. While at first, the majority of COVID-19 diagnostic testing in the USA took place in healthcare settings, quickly a direct-to-consumer (DTC) testing market also emerged. In these DTC provision mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalokairinou, Louiza, Zettler, Patricia J, Nagappan, Ashwini, Kyweluk, Moira A, Wexler, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543538/
https://www.ncbi.nlm.nih.gov/pubmed/33569177
http://dx.doi.org/10.1093/jlb/lsaa069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543538/
https://www.ncbi.nlm.nih.gov/pubmed/33569177
http://dx.doi.org/10.1093/jlb/lsaa069

Ejemplares similares